Cargando…
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune and chronic inflammatory demyelinating disease of the central nervous system (CNS), which gives rise to focal lesion in CNS and cause physical disorders. Although environmental factors and susceptibility genes are reported to play a role in the pathogenesis o...
Autores principales: | Wei, Weipeng, Ma, Denglei, Li, Lin, Zhang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313804/ https://www.ncbi.nlm.nih.gov/pubmed/34326775 http://dx.doi.org/10.3389/fphar.2021.724718 |
Ejemplares similares
-
Cornel Iridoid Glycoside Ameliorated Alzheimer's Disease-Like Pathologies and Necroptosis through RIPK1/MLKL Pathway in Young and Aged SAMP8 Mice
por: Ma, Denglei, et al.
Publicado: (2021) -
Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice
por: Ma, Denglei, et al.
Publicado: (2021) -
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022) -
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022) -
Research progress of natural silk fibroin and the application for drug delivery in chemotherapies
por: Yu, Bin, et al.
Publicado: (2023)